Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis

Published:2016-05-13 Issue:8 Volume:18 Page:783-794
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Zaccardi F.¹²,Webb D. R.¹²,Htike Z. Z.¹²,Youssef D.¹²,Khunti K.¹²,Davies M. J.¹²

Affiliation:

1. Diabetes Research Centre, University of Leicester; Leicester UK

2. Diabetes Research Center, Leicester Diabetes Centre, UHL NHS Trust; Leicester UK

Funder

National Institute for Health Research

Leicester Clinical Trials Unit

NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit

Novartis

Novo Nordisk

Sanofi-Aventis

Eli Lilly and Company

Pfizer

Boehringer Ingelheim

Merck Sharp & Dome

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12670/fullpdf

Reference74 articles.

1. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus;Defronzo;Diabetes,2009

2. Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes;Holman;Lancet,2014

3. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetologia,2015

4. Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport;Abdul-Ghani;J Intern Med,2014

5. SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects;Ferrannini;Nat Rev Endocrinol,2012

Cited by 359 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated analysis reveals ceRNA network of cardiac remodeling by SGLT2 inhibitor in middle-aged hypertensive rats;Biochemical and Biophysical Research Communications;2024-02

2. SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes;Renal Replacement Therapy;2024-01-31

3. Sodium–glucose linked transporter 2 inhibitors in liver cirrhosis: Beyond their antidiabetic use;Liver International;2024-01-31

4. Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value‐based healthcare approach and systematic benefit‐risk assessment;Journal of Inherited Metabolic Disease;2024-01-07

5. Empagliflozin Exacerbated Lipid Metabolism Disorders in Diabetic Mice;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3